SSEA-5, an antibody defining a novel surface glycan on human pluripotent stem cells and its application to remove teratoma-forming cells as part of a surface antibody panel

A significant risk in the clinical application of human pluripotent stem cells (hPSCs), including human embryonic and induced pluripotent stem cells (hESCs and hiPSCs), is teratoma formation from residual undifferentiated cells. We have raised a monoclonal antibody (mAb) against hESCs, designated SS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tang, Chad, Lee, Andrew S., Volkmer, Jens-Peter, Sahoo, Debashis, Nag, Divya, Mosley, Adriane R., Inlay, Matthew A., Ardehali, Reza, Chavez, Shawn L., Pera, Renee Reijo, Behr, Barry, Wu, Joseph C., Weissman, Irving L., Drukker, Micha
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537836/
https://ncbi.nlm.nih.gov/pubmed/21841799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.1947
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados